Trial Profile
Retrospective Data Analysis of Newly Diagnosed Crohn's Disease Patients in Gastroenterological Surgeries
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 03 Jun 2011
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms Crohn 2
- Sponsors Ferring Pharmaceuticals
- 03 Jun 2011 New trial record